Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Eli Lilly and Company revenue
Eli Lilly and Company's revenue is $45.0 billion.
What is Eli Lilly and Company's revenue?
- Eli Lilly and Company's revenue growth from 1999 to 2024 is 350.3%.
- Eli Lilly and Company has 33,625 employees, and the revenue per employee ratio is $1,339,559.
- Eli Lilly and Company's peak quarterly revenue was $13.5B in 2024(q4).
- Eli Lilly and Company peak revenue was $45.0B in 2024.
- Eli Lilly and Company annual revenue for 2023 was 34.1B, 19.56% growth from 2022.
- Eli Lilly and Company annual revenue for 2024 was 45.0B, 32.0% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Eli Lilly and Company historical revenue
Eli Lilly and Company's peak revenue was $45.0B in 2024. The peak quarterly revenue was $13.5B in 2024(q4).
Eli Lilly and Company's revenue increased from $10.0b in 1999 to $45.0B currently. That's a 350.3% change in annual revenue.
Eli Lilly and Company annual revenue
Eli Lilly and Company annual revenue over time
| Fiscal year / year | Eli Lilly and Company revenue |
|---|---|
| 2009 | $21.8B |
| 2010 | $23.1B |
| 2011 | $24.3B |
| 2012 | $22.6B |
| 2013 | $23.1B |
| 2014 | $19.6B |
| 2015 | $20.0B |
| 2016 | $21.2B |
| 2017 | $22.9B |
| 2018 | $21.5B |
| 2019 | $22.3B |
| 2020 | $24.5B |
| 2021 | $28.3B |
| 2022 | $28.5B |
| 2023 | $34.1B |
| 2024 | $45.0B |
How accurately did Eli Lilly and Company's revenue projections match actual performance?
Eli Lilly and Company annual growth
Eli Lilly and Company saw the greatest revenue growth in 2007, when revenue increased by 18.75%.
Eli Lilly and Company had the lowest revenue growth in 2014, when revenue changed by -15.13%.
Eli Lilly and Company annual growth rate over time
| Year | Eli Lilly and Company growth |
|---|---|
| 2009 | 7%↑ |
| 2010 | 6%↑ |
| 2011 | 5%↑ |
| 2012 | -7%↓ |
| 2013 | 2%↑ |
| 2014 | -15%↓ |
| 2015 | 2%↑ |
| 2016 | 6%↑ |
| 2017 | 8%↑ |
| 2018 | -6%↓ |
| 2019 | 4%↑ |
| 2020 | 10%↑ |
| 2021 | 15%↑ |
| 2022 | 1%↑ |
| 2023 | 20%↑ |
| 2024 | 32%↑ |
Eli Lilly and Company quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Eli Lilly and Company quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | - | - | $5.6B | $5.9B |
| 2010 | $5.5B | $5.7B | $5.7B | $6.2B |
| 2011 | $5.8B | $6.3B | $6.1B | $6.0B |
| 2012 | $5.6B | $5.6B | $5.4B | $6.0B |
| 2013 | $5.6B | $5.9B | $5.8B | $5.8B |
| 2014 | $4.7B | $4.9B | $4.9B | $5.1B |
| 2015 | $4.6B | $5.0B | $5.0B | $5.4B |
| 2016 | $4.9B | $5.4B | $5.2B | $5.8B |
| 2017 | $5.2B | $5.8B | $5.7B | $3.3B |
| 2018 | $5.0B | $5.6B | $5.3B | $5.7B |
| 2019 | $5.1B | $5.6B | $5.5B | $6.1B |
| 2020 | $5.9B | $5.5B | $5.7B | $7.4B |
| 2021 | $6.8B | $6.7B | $6.8B | $8.0B |
| 2022 | $7.8B | $6.5B | $6.9B | $7.3B |
| 2023 | $7.0B | $8.3B | $9.5B | $9.4B |
| 2024 | $8.8B | $11.3B | $11.4B | $13.5B |
Eli Lilly and Company jobs nearby
Do you work at Eli Lilly and Company?
Did Eli Lilly and Company meet its revenue projections?
Eli Lilly and Company financial information
| CEO | David A. Ricks |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 33,625 |
| Date Founded | 1876 |
| Headquarters | Indianapolis, Indiana |
| Number of Locations | 11 |
| Revenue | $45.0B |
| Net Income | $6,244,800,000 |
| Gross Proft | $36.6B (2024) |
| PE Ratio | 8.16 |
| Tax Rate | 0.2% |
| Market Capitalization | $86.5B |
| Total Assets | $49,489,800,000 |
| Ticker | LLY |
Eli Lilly and Company jobs you might like
Eli Lilly and Company competitors
Eli Lilly and Company's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Eli Lilly and Company's smallest competitor is Icos with revenue of $71.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | $90,328 | $64.2B | 74,000 | 1,539 |
| Bristol-Myers Squibb | $101,824 | $48.3B | 30,000 | 2,043 |
| Novartis | $112,479 | $51.7B | 110,000 | 394 |
| Boehringer Ingelheim | $106,981 | $17.2B | 52,391 | 351 |
| AstraZeneca | $112,988 | $25.9B | 76,100 | 386 |
| Pfizer | $70,868 | $63.6B | 78,500 | 378 |
| Glaxosmithkline | $68,587 | $34.1B | 99,000 | 5 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,704 |
| Elanco | $70,606 | $4.4B | 10,200 | 125 |
| Icos | $74,536 | $71.4M | 700 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Eli Lilly and Company highest paying jobs
Zippia gives an in-depth look into the details of Eli Lilly and Company, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Eli Lilly and Company. The employee data is based on information from people who have self-reported their past or current employments at Eli Lilly and Company. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Eli Lilly and Company. The data presented on this page does not represent the view of Eli Lilly and Company and its employees or that of Zippia.
Eli Lilly and Company may also be known as or be related to Eli Lilly And Company, Eli Lilly and Company, Eli Lilly & Co. Foundation, Inc. and Eli Lilly.